• List
• Write
• 게시판 리스트 옵션
  • Modity
  • Delete

Cryogenic Storage Systems Market: Advancing Biopreservation and Life Sciences

Cryogenic storage systemshave become an essential part of modern life sciences, enabling biological materials to be preserved at ultra-low temperatures for extended periods. These systems support applications ranging from biobanking and reproductive medicine to cell and gene therapy, pharmaceutical cold chain storage, and academic research. As demand for advanced biological products increases, reliable temperature-controlled storage is becoming increasingly important across healthcare and biotechnology facilities.

According to Emergen Research, the global cryogenic storage systems market was valued at USD 5.15 billion in 2025 and is projected to reach USD 12.85 billion by 2035, registering a compound annual growth rate (CAGR) of 9.6% from 2026 to 2035. The market is estimated at USD 5.65 billion in 2026, reflecting continued investment in specialized storage infrastructure and monitoring technologies.

Growing Demand for Biological Preservation

The expansion of biobanking, cell and gene therapy, and pharmaceutical research is a major factor supporting the cryogenic storage systems market. These applications require stable, precisely controlled temperatures to protect biological samples and maintain their quality over long storage periods. Cryogenic systems can preserve cells, tissues, plasma, reproductive materials, and manufactured cell and gene therapy products at temperatures low enough to halt biological activity.

The increasing use of advanced therapies is also creating demand for dependable storage infrastructure. Pharmaceutical and biotechnology companies are expanding their capabilities for developing and manufacturing sophisticated biological products, increasing the need for storage systems that can maintain stringent temperature conditions throughout the product lifecycle.

Get a Sample: https://www.emergenresearch.com/request-free-sample/220414 

Cryogenic Freezers Lead the Product Segment

Cryogenic freezers accounted for the largest share of the market by product type, representing 42.6% of global revenue in 2025. These systems are widely used across research facilities, biobanks, pharmaceutical companies, and healthcare institutions. Liquid nitrogen storage systems, cryogenic vials and consumables, and monitoring and software systems also form important parts of the market.

Monitoring and software systems are expected to record the fastest growth, with a projected CAGR of 11.4% through 2035. Continuous monitoring has become increasingly important because even small temperature deviations can affect valuable biological materials. These capabilities strengthen operational reliability and help reduce risks from temperature excursions.

Ultra-Low Temperature Storage Supports Long-Term Stability

By temperature range, the -150°C to -196°C segment held the largest market share at 46.8% in 2025. This range covers many liquid and vapor-phase nitrogen storage conditions used for long-term preservation of biological materials, including cell and gene therapy products, reproductive tissue, and biobank samples.

The below -196°C segment is projected to grow at the fastest CAGR of 9.9% through 2035. Increasing requirements for extremely low-temperature storage in certain advanced cell and stem cell therapy applications are contributing to this growth. Meanwhile, the -80°C to -150°C category remains important for mechanical ultra-low-temperature freezer applications.

Cell and Gene Therapy Drive Application Growth

Cell and gene therapy biobanking represented the largest application segment, accounting for 34.2% of market revenue in 2025. The growing development and commercialization of advanced therapies are increasing requirements for secure storage before treatment, during manufacturing, and across distribution processes.

Pharmaceutical cold chain storage is projected to expand at the fastest CAGR of 10.8% through 2035. Maintaining appropriate temperatures is essential for protecting sensitive pharmaceutical and biological products, making specialized cryogenic infrastructure increasingly relevant to modern supply chains.

Pharmaceutical Companies Remain Key End Users

Pharmaceutical and biotechnology companies accounted for 46.4% of the market in 2025 and are projected to register the fastest CAGR of 10.6% through 2035. These organizations increasingly require high-capacity storage for research samples, biological materials, and advanced therapies.

Hospitals and fertility clinics represent another important end-user group, particularly because of reproductive medicine and the increasing use of cell-based treatments. Academic and research institutes also continue to use cryogenic storage for laboratory samples and long-term biological research.

North America Leads While Asia Pacific Expands Rapidly

North America held the largest regional share, accounting for 40.4% of global revenue in 2025. The region benefits from a strong biopharmaceutical industry, established research infrastructure, and the presence of specialized cryogenic storage providers.

Asia Pacific is projected to register the fastest growth during the forecast period. China led the regional market in 2025, supported by expanding cell and gene therapy manufacturing and pharmaceutical quality requirements. Japan and India also contribute to regional demand through pharmaceutical manufacturing, research, biobanking, and fertility-related applications.

Technology and Monitoring Shape Future Development

The evolution of cryogenic storage is increasingly connected with digital monitoring and system automation. Facilities handling irreplaceable samples require continuous visibility into storage conditions, while connected monitoring platforms can improve operational oversight. Manufacturers are therefore focusing on systems that combine reliable temperature performance with advanced monitoring and control capabilities.

At the same time, the market continues to depend on an integrated value chain involving insulation and vacuum-vessel manufacturing, freezer and dewar production, system integration, installation, monitoring, liquid nitrogen supply, and replacement components. Reliable coordination across these stages is important for maintaining uninterrupted storage operations.

Competitive Landscape

The global cryogenic storage systems market is moderately fragmented, with large and medium-sized companies competing through product development, strategic agreements, acquisitions, and expanded service capabilities. Major companies profiled by Emergen Research include Cryoport Inc., Chart Industries Inc., Thermo Fisher Scientific Inc., Taylor-Wharton International LLC, Custom Biogenic Systems Inc., Azenta Life Sciences Inc., Eppendorf SE, PHC Holdings Corporation, Air Liquide S.A., and Worthington Enterprises Inc.

Read More: https://www.emergenresearch.com/industry-report/cryogenic-storage-systems-market 

Future Outlook

The cryogenic storage systems market is positioned for sustained expansion as biobanking, cell and gene therapy, reproductive medicine, pharmaceutical research, and advanced biological manufacturing continue to develop. With the market expected to rise from USD 5.15 billion in 2025 to USD 12.85 billion by 2035, investments in high-performance freezers, liquid nitrogen systems, and digital monitoring technologies are expected to remain important. As biological products become more sophisticated, dependable cryogenic storage will continue to play a critical role in protecting valuable materials and supporting the growth of life-science industries.